Literature DB >> 18761662

25 years of HIV research on virology, virus restriction, immunopathogenesis, genes and vaccines.

E Scherer1, D Douek, A McMichael.   

Abstract

From 19 to 21 May 2008 an important meeting was held at the Pasteur Institute in Paris to mark the 25th Anniversary of the discovery of HIV as the aetiological agent of AIDS. This review summarizes the historical findings, recent work and future directions presented at this meeting.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18761662      PMCID： PMC2561096          DOI： 10.1111/j.1365-2249.2008.03750.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  38 in total

1.  Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.

Authors:  J R Mascola; G Stiegler; T C VanCott; H Katinger; C B Carpenter; C E Hanson; H Beary; D Hayes; S S Frankel; D L Birx; M G Lewis
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore.

Authors:  Nathalie J Arhel; Sylvie Souquere-Besse; Sandie Munier; Philippe Souque; Stéphanie Guadagnini; Sandra Rutherford; Marie-Christine Prévost; Terry D Allen; Pierre Charneau
Journal:  EMBO J       Date:  2007-06-07       Impact factor: 11.598

3.  Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses.

Authors:  N Sagata; T Yasunaga; J Tsuzuku-Kawamura; K Ohishi; Y Ogawa; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Inefficient human immunodeficiency virus replication in mobile lymphocytes.

Authors:  Marion Sourisseau; Nathalie Sol-Foulon; Françoise Porrot; Fabien Blanchet; Olivier Schwartz
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

5.  In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers.

Authors:  Alexandra Trkola; Herbert Kuster; Peter Rusert; Viktor von Wyl; Christine Leemann; Rainer Weber; Gabriela Stiegler; Hermann Katinger; Beda Joos; Huldrych F Günthard
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

6.  Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence.

Authors:  Ivona V Pandrea; Rajeev Gautam; Ruy M Ribeiro; Jason M Brenchley; Isolde F Butler; Melissa Pattison; Terri Rasmussen; Preston A Marx; Guido Silvestri; Andrew A Lackner; Alan S Perelson; Daniel C Douek; Ronald S Veazey; Cristian Apetrei
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

7.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

Review 8.  Patterns of evolution of host proteins involved in retroviral pathogenesis.

Authors:  Millan Ortiz; Gabriela Bleiber; Raquel Martinez; Henrik Kaessmann; Amalio Telenti
Journal:  Retrovirology       Date:  2006-02-07       Impact factor: 4.602

9.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

10.  Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.

Authors:  Galit Alter; Maureen P Martin; Nickolas Teigen; William H Carr; Todd J Suscovich; Arne Schneidewind; Hendrik Streeck; Michael Waring; Angela Meier; Christian Brander; Jeffrey D Lifson; Todd M Allen; Mary Carrington; Marcus Altfeld
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307
View more
  4 in total

1.  What does the report of the USMHRP Phase III study in Thailand mean for HIV and for vaccine developers?

Authors:  Barney S Graham
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

2.  Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy.

Authors:  Gülşen Ozkaya Sahin; Emma J Bowles; Joe Parker; Hannes Uchtenhagen; Enas Sheik-Khalil; Stephen Taylor; Oliver G Pybus; Barbro Mäkitalo; Lilian Walther-Jallow; Mats Spångberg; Rigmor Thorstensson; Adnane Achour; Eva Maria Fenyö; Guillaume B E Stewart-Jones; Anna-Lena Spetz
Journal:  PLoS Pathog       Date:  2010-09-02       Impact factor: 6.823

3.  Smallest organism; highest threat.

Authors:  Amit Pant; Rupesh Chikhale; Pankaj Wadibhasme; Sunil Menghani; Pramod Khedekar
Journal:  Mater Sociomed       Date:  2012

4.  Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors.

Authors:  Sachin Gupta; James M Termini; Biju Issac; Elizabeth Guirado; Geoffrey W Stone
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.